Department of Vascular and Interventional Radiology, Ghent University Hospital, De Pintelaan 185, 9000, Ghent, Belgium.
Cardiovasc Intervent Radiol. 2012 Jun;35(3):598-606. doi: 10.1007/s00270-011-0188-9. Epub 2011 Jun 3.
This was a prospective, randomized, blinded comparative study of the efficacy and safety of two different n-butyl-2-cyanoacrylates (NBCAs) for embolization of varicoceles.
A total of 112 insufficient spermatic veins (left-sided, n=84; right-sided, n=28) that were diagnosed in 83 adult males were prospectively randomized for blinded embolization with NBCA (n=54; Histoacryl, Braun, Germany) or NBCA-MS (n=58; Glubran2, General Enterprise Marketing, Viareggio, Lucca, Italy). Handling, embolic efficacy, and safety of both NBCAs were compared according the fulfillment of a standardized embolization plan, the occlusive effect on the spermatic vein, and the sticking to the microcatheter. Statistical analysis was performed with the Mann-Whitney U test and the Fisher's exact test.
Patients of both study arms were comparable for age and clinical indication. Spermatic vein characteristics were comparable for varicocele classification and embolization side. Both NBCAs were equally efficient in occluding the spermatic vein and blocking reflux (NBCA, n=54/54, 100% vs. NBCA-MS, n=54/57, 94.7%; P=0.244). The embolization plan could be accomplished in an equal number of veins for both groups (NBCA, n=45/54, 83.3% vs. NBCA-MS, n=41/58, 70.7%; P=0.124). Adhesiveness of the glue to the microcatheter was the same in both NBCA groups (NBCA, n=25/54, 46.3% vs. NBCA-MS, n=29/58, 50%; P=0.71). No glue-related complications were noted.
NBCA and NBCA-MS are equally efficient and safe glues for embolization of varicoceles.
本研究为前瞻性、随机、盲法比较两种不同丁基-2-氰基丙烯酸酯(NBCA)用于精索静脉曲张栓塞的疗效和安全性。
前瞻性纳入 83 例成年男性共 112 条精索静脉(左侧 84 条,右侧 28 条),随机分为两组,分别采用 NBCA(Histoacryl,Braun,德国)或 NBCA-MS(Glubran2,General Enterprise Marketing,Viareggio,Lucca,意大利)进行盲法栓塞。根据标准化栓塞方案的实施、对精索静脉的闭塞效果和微导管的黏附情况比较两种 NBCA 的处理、栓塞效果和安全性。采用 Mann-Whitney U 检验和 Fisher 确切概率法进行统计学分析。
两组患者的年龄和临床适应证相似。精索静脉特征在精索静脉曲张分级和栓塞侧方面相似。两种 NBCA 均能有效闭塞精索静脉并阻断反流(NBCA,n=54/54,100% vs. NBCA-MS,n=54/57,94.7%;P=0.244)。两组均有相同数量的静脉能完成栓塞计划(NBCA,n=45/54,83.3% vs. NBCA-MS,n=41/58,70.7%;P=0.124)。两种 NBCA 组的胶黏附于微导管的黏附性相同(NBCA,n=25/54,46.3% vs. NBCA-MS,n=29/58,50%;P=0.71)。未观察到与胶相关的并发症。
NBCA 和 NBCA-MS 是用于精索静脉曲张栓塞的同样有效且安全的胶黏剂。